MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibility.
Xin WeiLi GuoHongliu CaiSilan GuLingling TangYuxin LengMinghui ChengGuojun HeYijiao HanXindie RenBaoyue LinLongxian LvHuanzhang ShaoMingqiang WangHongyu WangDan DangShengfeng WangNan WangPeng ShenQianqian WangYinghe XuYongpo JiangNing ZhangXuwei HeXuntao DengMuhua DaiLin ZhongYonghui XiongYujie PanKankai TangFengqi LiuBin YangLili RenJianwei WangChao JiangLingtong HuangPublished in: iMeta (2024)
The MASS cohort comprises 2000 ICU patients with severe pneumonia, covering community-acquired pneumonia, hospital-acquired pneumonia, and ventilator-associated pneumonia, sourced from 19 hospitals across 10 cities in three provinces. A wide array of samples including bronchoalveolar lavage fluid, sputum, feces, and whole blood are longitudinally collected throughout patients' ICU stays. The cohort study seeks to uncover the dynamics of lung and gut microbiomes and their associations with severe pneumonia and host susceptibility, integrating deep metagenomics and transcriptomics with detailed clinical data.
Keyphrases
- community acquired pneumonia
- end stage renal disease
- intensive care unit
- healthcare
- early onset
- respiratory failure
- ejection fraction
- cross sectional
- chronic kidney disease
- single cell
- peritoneal dialysis
- mycobacterium tuberculosis
- clinical trial
- drug induced
- emergency department
- prognostic factors
- big data
- high throughput
- mass spectrometry
- pulmonary tuberculosis
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation